Abiopharma

CANNAPHARMARX INC. (CPMD)

Symbol	CPMD
Name	CANNAPHARMARX INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	T2P 5C5 Canada AB Suite 3600 888 - 3rd Street SW
Telephone	+1 403-637-0420
Fax	—
Email	—
Website	http://www.cannapharmarx.com
Incorporation	US
Incorporated On	2014
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Barzily&Co Certified Public Accountants;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001081938
Description	CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the "endocannabinoid system" -- one of the most widely expressed system of receptors in the human body. CannaPharmaRx is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology. Additional info from OTC: CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the "endocannabinoid system" -- one of the most widely expressed system of receptors in the human body. CannaPharmaRx is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology.

2025-10-10 15:54

(99% Neutral) CannaPharmaRX, Inc. (CPMD) Provides Business Update

2025-08-22 13:12

📋 Tal Amir David (Right to appoint up to three board members) plans to sell 21.0M shares of Cannapharmarx (at $0.00 each, total $63K) Filed: Aug 22, 2025 | ID: 000002

2025-08-14 00:00

(51% Neutral) CANNAPHARMARX, INC. (CPMD) Reports 202% Loss Increase for 2025-06-30

2025-05-22 19:03

📋 Tal Amir David (Right to appoint up to three board members) plans to sell 20.0M shares of CANNAPHARMARX, INC. (at $0.00 each, total $66K) Filed: May 22, 2025 | ID: 000001

2025-05-16 17:53

New Form NT 10-Q - CANNAPHARMARX, INC. Filed: 2025-05-16 AccNo: 0001654954-25-005804 Size: 31 KB

2025-05-16 00:00

(27% Negative) CANNAPHARMARX, INC. (CPMD) Reports 1596% Loss Increase for 2025-03-31

2025-05-06 17:58

(70% Positive) CannapharmaRX, Inc. (CPMD) Files Form 8-K

2025-04-11 01:44

New Form 3 - CANNAPHARMARX, INC. Filed: 2025-04-10 AccNo: 0001213900-25-030783 Size: 7 KB

2025-04-11 01:43

New Form 3 - CANNAPHARMARX, INC. Filed: 2025-04-10 AccNo: 0001213900-25-030782 Size: 8 KB

2025-04-01 17:47

New Form NT 10-K - CANNAPHARMARX, INC. Filed: 2025-04-01 AccNo: 0001654954-25-003787 Size: 21 KB